None None
CEO
Allurion
Allurion Technologies has developed a non-surgical medical device for weight loss that can be delivered and removed without the need for endoscopy. This device addresses the challenges of obesity by providing a less invasive option for patients seeking effective weight management solutions.
- Digital Health
- Hardware
- Healthcare Technology
- Software Only
Updated 22 months ago
Funding
Raised to date
$2.5MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Obesity and excess weight can lead to increased risks of type 2 diabetes, cardiovascular diseases, sleep apnea, and certain cancers, yet sustained weight loss through diet and exercise alone is often challenging to achieve. Traditional weight-loss interventions may involve invasive procedures or require significant lifestyle adjustments that are difficult for some individuals to maintain.
Solution
Allurion Technologies offers a comprehensive weight-loss program centered around a non-surgical, swallowable gastric balloon. The Allurion Balloon is placed in the stomach during a brief outpatient visit, without the need for endoscopy or anesthesia. Once in place, the balloon occupies space in the stomach, promoting satiety and reducing food intake. The program includes personalized support from a multidisciplinary team of healthcare professionals, including nutritionists, and access to digital tools for progress tracking and remote monitoring. After approximately four months, the balloon automatically deflates and passes naturally through the digestive system, while patients continue to receive support to maintain their weight loss.
Target Audience
The Allurion program is designed for individuals with a Body Mass Index (BMI) of 27 or higher who are seeking a non-surgical weight-loss solution and are committed to making lifestyle changes with the support of a healthcare team.
Features
- Gastric balloon placement without surgery, endoscopy, or anesthesia
- Capsule-based delivery system for easy swallowing during a 20-minute outpatient visit
- Polyurethane balloon material designed to adapt to the patient's stomach shape
- Balloon self-empties and is naturally eliminated after approximately 4 months
- Multidisciplinary support team, including doctors and nutritionists, providing personalized guidance
- Allurion Virtual Care Suite for remote patient monitoring and telehealth consultations
- Allurion Connected Scale for tracking weight, BMI, and body composition
- Mobile app for monitoring progress, connecting with the care team, and accessing educational content